Heidelberg Pharma AG
HPHA · Xetra
Public Market Listing
HPHAXetra
Live quotes, historical charts, and market capitalization for Heidelberg Pharma AG are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
| Phase 1/2 | BCMAAntibody–drug conjugate | Multiple Myeloma |
Upcoming events
(1 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
2028 (1)
March 2028 (1)
Est. primary completion 2028-03 · NCT04879043 · CT.gov ↗
What to watch
Financial reports
Quarterly & interim (1)
| Period | Revenue | R&D | Cash & equiv. | Net loss / qtr | Filing |
|---|---|---|---|---|---|
| 2025-H1 | $1.5M | $15M | $38M | $6.8M | report ↗ |